Welcome to Pritzker | Ruohonen

Ortho Evra Birth Control Patch and Heart Attack

Women who use the Ortho Evra birth control patch are exposed to about 60 percent more total estrogen in their blood than if they were taking a typical birth control pill.  This increase in estrogen can lead to a blood clot, which can lead to a heart attack. As a public service, the lawyers at Pritzker | Ruohonen & Associates are providing the following information for women on heart attack symptoms.  We have also provided information on Ortho Evra and Strokes.

If you use or have used the Ortho Evra birth control patch and have had a heart attack, a lawyer at Pritzker | Ruohonen is available for a free consultation.  Our lawyers have years of experience and a record of success with product liability lawsuits, including a recent settlement for $3,750,000.   Johnson & Johnson has already settled several Ortho Evra lawsuits, contact us to help you with your Ortho Evra case.  You can reach us toll-free at 1-888-377-8900, by e-mail at info@pritzkerlaw.com, or by filling out our online consultation form.

Ortho Evra – Heart Attack Symptoms
If you use Ortho Evra, you should know the symptoms of heart attack.  Be aware that heart attack symptoms in women are usually different than in men.

  • Chest pain: Although chest pain is the symptom most commonly associated with heart attack, many women having a heart attack do not experience chest pain.  If there is chest pain, it often is in the center of the chest and lasts for more than a few minutes. It often radiates from the chest to the arms, shoulder, neck, teeth, jaw, abdomen, or back. It can feel like:
    • squeezing or heavy pressure
    • a tight band on the chest
    • "an elephant sitting on [your] chest"
    • bad indigestion
      For women, the pain may be quite mild. If you are using Ortho Evra, you are at higher risk for heart attack and should seek immediate medical attention even if there is mild chest pain.
  • Pain or discomfort in other areas of the upper body: As discussed above, chest pain can radiate from the chest to the arms, shoulder, neck, teeth, jaw, abdomen, or back. It is also possible for there to be pain in one of these areas without accompanying chest pain. The most common areas for pain and discomfort for women are the chest, back, neck and jaw.
  • Shortness of breath: Shortness of breath may occur at the same time as chest pain, or it may occur before it. Women have shortness of breath more than men.
  • Breaking into a cold sweat: Men sweat when they are experiencing a heart attack more often than women.
  • Pain in one or both arms: Pain radiating down the left arm is a well-known symptom of heart attack; however, pain in either arm can be a symptom of heart attack.
  • Nausea: The nausea can lead to vomiting.
  • Indigestion: It can be hard to tell between bad indigestion and a heart attack. It is best to get immediate medical attention.
    Fatigue: Usually when fatigue is a symptom, the fatigue is severe.
  • Dizziness: The severity of this symptom can vary from feeling very dizzy to just feeling lightheaded.

Women are more likely to experience nausea, vomiting, or indigestion as heart attack symptoms. Remember, you are at higher risk for heart attack if you are using Ortho Evra. Mild symptoms should not be disregarded.

Sources:
The National Women’s health Information Center, a service of the U.S. Departement of Health and Human Services
http://www.womenshealth.gov/heart/
HeartHealthyWomen
http://www.hearthealthywomen.org/
Medline Plus: a service of the U.S. National Library of Medicine and the National Institutes of Health
http://www.nlm.nih.gov/medlineplus/ency/article/001124.htm


Free Case Consultation





Logos

Unsafe Medical Featured Topics

Deaths Prompt Warnings for Haldol

The WARNINGS section of the prescribing information for Haldol (haloperidol, an antipsychotic medication), a Johnson & Johnson product, has been revised to include a new cardiovascular (heart-related) subsection regarding cases of sudden death, QT prolongation and torsades de pointes(TdP) in patients treated with haloperidol, especially when given intravenously, or at doses higher than recommended. Read more about haloperidol and a Haldol (haloperidol) lawsuit.

 

Deaths of Patients Treated with FENTORA

There have been serious, adverse events, including deaths in patients treated with FENTORA (fentanyl buccal tablet). According to the manufacturer of FENTORA, Cephalon, “These deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients), improper dosing, and/or improper product substitution.” Read FENTORA lawsuit and lawyer information.

 

New Boxed Warning for Xolair

Anaphylaxis (severe allergic reaction) has occurred in some patients who were administered Xolair, an asthma medication manufactured by Genentech, Inc. 15% of the reported cases required hospitalization. Learn more about the Xolair boxed warning.

 

Ceftin, Fortaz, Rocephin, and Zinacef

Ceftin, Fortaz, Rocephin, and Zinacef (cephalosporin-based antibiotic medications) can cause pseudomembranous colitis, severe inflammation in areas of the colon (large intestine). Children are particularly susceptible to developing antibiotic-related colitis, which can cause serious illness and death. Read about the new label precautions and warnings for Ceftin, Fortaz, Rocephin, and Zinacef.

 

Continued Risks of Duragesic and Fentanyl

In July of 2005, the FDA issued an advisory regarding reports of death and other serious side effects from overdoses of fentanyl in patients using fentanyl transdermal (skin) patches for pain control. Deaths and overdoses had occurred in patients using both the brand name product Duragesic and the generic product (at the time there was only one generic product).

 

Complete Moisture Plus Recall

The FDA has announced that many consumers may not be aware of the May 2007 recall of Complete MoisturePlus Multipurpose Contact Lens Solution manufactured by Advanced Medical Optics (AMO). Learn more about the recall and a Complete Moisture Plus lawsuit.

 

Infant Deaths May Be Linked to Rocephin

Rocephin (ceftriaxone sodium) may be linked to the deaths of newborn infants. The babies most at risk are premature infants who are hyperbilirubinemic (a condition associated with jaundice). Learn more about Rocephin and the risk of death or injury.

 

Colistimethate May Have Caused Death

The FDA has received a report about the death of a patient with cystic fibrosis (CF) who used the antibiotic Colistimethate that had been premixed by a pharmacy into a liquid for inhalation with a nebulizer. Learn more about Colistimethate.